Showing results (2281-2290 of 2,546) with videos related to

Sort By:
Pageof 255
Frontiers in Oncology|December 19, 2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experienceFrancesco Autore, Luca Stirparo, Idanna Innocenti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019
Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomesFabio Efficace, Franco Mandelli, Giuseppe Avvisati, et al.
Current Cancer Drug Targets|March 18, 2014
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenograftsShijun Zhu, Terry W Moore, Nao Morii, et al.
Journal of Biomedical Science|February 18, 2026
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammationFederica Laudisi, Mattia Alberto Serra, Lorenzo Tomassini, et al.
Blood|April 24, 2024
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMTJaime Sanz, Myriam Labopin, Goda Choi, et al.
Frontiers in Molecular Biosciences|March 11, 2021
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 InfectionElettra Barberis, Virginia V Vanella, Marco Falasca, et al.
JMIR Cancer|January 6, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot StudyLemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov, et al.
Journal for Immunotherapy of Cancer|March 25, 2025
Single-cell analysis of oncolytic virotherapy in adult T-cell leukemia/lymphomaJianhong An, Erqiang Hu, Yang Shi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancerSuresh S Ramalingam, Taofeek K Owonikoko, Madhusmita Behera, et al.
Pageof 255